Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK21542 for Postoperative Pain Treatment in Orthopedic Surgery
NCT07186426Phase 3Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hsk21542 in postoperative pain, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Aug 2025; status: completed.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07186426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07186426.